The arthus reaction in rodents: Species-specific requirement of complement

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 463-468

  Szalai, Alexander J ^a   Digerness, Stanley B ^b   Agrawal, Alok ^a,g   Kearney, John F ^c   Bucy, R Pat ^d   Niwas, Shri ^e   Kilpatrick, John M ^e   Babu, Y Sudhakara ^e   Volanakis, John E ^a,f  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e BIOCRYST PHARMACEUTICALS INC   (United States)

^f BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^g METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCX 1470; COMPLEMENT; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ARTHUS PHENOMENON; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; GUINEA PIG; HEMOLYSIS; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SKIN INFLAMMATION; SPECIES DIFFERENCE;

EID: 0033962017     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.463     Document Type: Article

References (32)

1. Ranadive, N. S., and H. Z. Movat. 1979. Tissue injury and inflammation induced by immune complexes. In Inflammation, Immunity, and Hypersensitivity: Cellular and Molecular Mechanisms. H. Z. Movat, ed. Harper & Row, Hagerstown, MA, pp. 409-443.
2. Fischel, E. E., and E. A. Kabat. 1947. A quantitative study of the Arthus phenomenon induced passively in the rabbit. J. Immunol. 55:337.
3. Benacerraf, B., and E. A. Kabat. 1950. A quantitative study of the Arthus phenomenon induced passively in the guinea pig. J. Immunol. 64:1.
4. Ward, P. A., and C. G. Cochrane. 1965. Bound complement and immunologic injury of blood vessels. J. Exp. Med. 121:215.
5. Ierino, F. L., M. S. Powell, I. F. C. McKenzie, and P. M. Hogarth. 1993. Recombinant soluble human FcγRII: production, characterization, and inhibition of the Arthus Reaction. J. Exp. Med. 178:1617.
6. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76:519.
7. Sylvestre, D. L., and J. V. Ravetch. 1994. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265:1095.
8. Sylvestre, D., R. Clynes, M. Ma, H. Warren, M. C. Carroll, and J. V. Ravetch. 1996. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med. 184:2385.
9. Hazenbos, W. L. W., J. E. Gessner, F. M. A. Hofhuis, H. Kuipers, D. Meyer, I. A. F. M. Heijnen, R. E. Schmidt, M. Sandor, P. J. A. Capel, M. Daëron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5:181.
10. Höpken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1997. Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 185:749.
11. Gresham, H. D., D. F. Matthews, and F. M. Griffin, Jr. 1986. Isolation of human complement component C3 from small volumes of plasma. Anal. Biochem. 154:454.
12. Niemann, M. A., J. E. Volanakis, and J. E. Mole. 1980. Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb. Biochemistry 19:1576.
13. Volanakis, J. E., and K. J. Macon. 1987. Isolation of complement protein D from urine of patients with Fanconi's syndrome. Anal. Biochem. 163:242.
14. Babu, Y. S., J. C. Bennet, S. Niwas, and R. S. Rowland. 1998. Novel compounds useful in the complement, coagulation, and kallikrein pathways and methods for their preparation. Patent No. WO 98/55471.
15. Lottenberg, R., U. Christensen, C. M. Jackson, and P. L. Coleman. 1981. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol. 80:341.
16. Kam, C.-M., B. J. McRae, J. W. Harper, M. A. Niemann, J. E. Volanakis, and J. C. Powers. 1987. Human complement proteins D, C2 and B: active site mapping with peptide thioester substrates. J. Biol. Chem. 262:3444.
17. Ueda, A., J. F. Kearney, K. H. Roux, and J. E. Volanakis. 1987. Probing functional sites on complement protein B with monoclonal antibodies: evidence for C3b-binding sites on Ba. J. Immunol. 138:1143.
18. Kim, S., S. V. L. Narayana, and J. E. Volanakis. 1995. Crystal structure of a complement factor D mutant expressing enhanced catalytic activity. J. Biol. Chem. 270:24399.
19. Cochrane, C. G., H. J. Müller-Eberhard, and B. S. Aikin. 1970. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immunol. 105:55.
20. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1996. Role of complement in C-reactive protein mediated protection of mice from Streptococcus pneumoniae. Infect. Immun. 64:4850.
21. Taktak, Y. S., and B. Stenning. 1992. Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute phase mouse sera. Horm. Metab. Res. 24:371.
22. Yeh, C. G., H. C. Marsh, Jr., G. R. Carson, L. Berman, M. F. Concino, S. M. Scesney, R. E. Kuestner, R. Skibbens, K. A. Donahue, and S. H. Ip. 1991. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive Arthus reaction in rats. J. Immunol. 146:250.
23. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052.
24. Heller, T., J. Engelbert Gessner, R. E. Schmidt. A. Klos, W. Bautsch, and J. Köhl. 1999. Cutting edge: Fc receptor type 1 for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J. Immunol. 162:5657.
25. Pflum, L. R., and M. L. Graeme. 1979. The Arthus reaction in rats, a possible test for antirheumatic drugs. Agents Actions 9:184.
26. Carter, G. W., M. K. Martin, R. A. Krause, and P. R. Young, 1982. The effects of anti-inflammatory and other agents on the rat dermal Arthus reaction. Res. Commun. Chem. Pathol. Pharmol. 35:189.
27. Junien, J. L., C. Lakatos, J. Brohon, M. Guillaume, and J. Sterne. 1982. Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation: investigation of the mechanism of action. Agents Actions 2:459.
28. Bailey, P. J., and A. Sturm. 1983. Immune complexes and inflammation: a study of the activity of anti-inflammatory drugs in the reverse passive Arthus reaction in the rat. Biochem. Pharmacol. 32:475.
29. Hyman, Y. G., and T. L. Vischer. 1978. Protease inhibitors reduce the reverse passive Arthus reaction. Agents Actions 8:532.
30. Bauman, N., J. A. Brockman, B. S. Pease, W. J. Elliott, and D. F. Colucci. 1981. Systematic discovery and evaluation of complement inhibitors. Immunopharmacology 3:317.
31. Hitomi, Y., and S. Fujii. 1982. Inhibition of various immunological reactions in vivo by a new synthetic complement inhibitor. Int. Archs. Allergy Appl. Immunol. 69:262.
32. Takahashi, M., S. Takahashi, V. Brade, and V. Nussenzweig. 1978. Requirements for the solubilization of immune aggregates by complement: the role of the classical pathway. J. Clin. Invest. 62:349.